Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age
Alcausin, M.B.; Briody, J.; Pacey, V.; Ault, J.; McQuade, M.; Bridge, C.; Engelbert, R.H.H. (Faculteit Gezondheid); Sillence, D.O.; Munns, C.F.






























